Form 4: West Pharmaceutical Services VP & Treasurer Charles Witherspoon Reports Stock Transactions
SEC Filing
Charles Witherspoon, VP & Treasurer of West Pharmaceutical Services, executed stock option exercises and sales on February 28, 2024.
Summary
- On February 28, 2024, Charles Witherspoon, VP & Treasurer of West Pharmaceutical Services, exercised stock options to acquire 2,019 shares of common stock at a price of $102.51 per share.
- Simultaneously, Witherspoon sold 2,019 shares of common stock at a price of $358.6238 per share.
- Following these transactions, Witherspoon directly owns 1,979.091 shares of West Pharmaceutical Services common stock.
- Witherspoon also directly owns 529 stock options.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the effect is likely minimal given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 02/19/2020 | Date stock options vest in four equal annual installments. |
| 02/28/2024 | Date of stock option exercise and sale of shares. |
| 02/19/2029 | Expiration date of stock options. |
| 03/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.